ロード中...

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly associated with the successful development of immune checkpoint inhibitors (ICIs) for multiple types of human tumors. Blockade with different ICIs, including programmed cell death 1 (PD-1),...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Song, Yuxiao, Fu, Yang, Xie, Qi, Zhu, Bo, Wang, Jun, Zhang, Bicheng
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477085/
https://ncbi.nlm.nih.gov/pubmed/32983126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01956
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!